Observational Study
Copyright ©The Author(s) 2017.
World J Gastroenterol. Mar 21, 2017; 23(11): 2052-2059
Published online Mar 21, 2017. doi: 10.3748/wjg.v23.i11.2052
Table 1 Patient characteristics at baseline (day 0 of steroid treatment) and day 7 of steroid treatment (n = 72) and survival at day 28, day 90 and 12 mo
Age47.9 ± 10.6
Male (%)74
Baseline CRP (mg/L)33 ± 26.8
Baseline bilirubin (μmol/L)294 ± 142
Baseline albumin (g/L)25 ± 7.7
Baseline INR1.9 ± 0.5
Baseline PT (s)19.2 ± 4.6
Baseline urea (μmol/L)3.9 ± 2.7
Baseline creatinine (μmol/L)90 ± 56.6
Baseline WBC (× 109/L)9.1 ± 4.5
Day 7 bilirubin (μmol/L)251 ± 174
Baseline DF53.0 ± 24.4
Baseline GAHS8.1 ± 1.4
Baseline MELD22.3 ± 6.7
Lille score0.403 ± 0.350
Day 28 survival (%)21
Day 90 survival (%)32
12 mo survival (%)43
Table 2 Univariate analysis of variables at baseline and day 7 of steroid treatment to assess association with day 90 outcome
Day 90 outcome
P value
Survivor (n = 49)Non-survivor (n = 23)
Age (yr)45530.01
Gender (% male)73741.00
Sepsis on admission (%)10130.50
Sepsis at any time (%)51481.00
Sepsis after steroids (%)33301.00
CRP (mg/L)30400.15
Baseline bilirubin (μmol/L)3012790.52
Baseline albumin (g/L)25240.38
Baseline INR1.820.14
Baseline PT (s)18.620.50.17
Baseline urea (μmol/L)3.25.5< 0.01
Baseline creatinine (μmol/L)90910.93
Baseline WBC (× 109/L)9100.44
Day 7 bilirubin (μmol/L)2442540.67
Baseline DF51.157.20.41
Baseline GAHS7.88.70.04
Baseline MELD21.723.70.23
Lille score0.380.460.38
Table 3 Multivariate regression analysis with 90 d outcome as the dependent variable and age and baseline urea as independent variables
R2Adjusted R2BStd. ErrorFSig
Model0.2050.1820.4258.87< 0.001
Constant-0.3510.2340.138
Urea0.0540.0200.010
Age0.0100.0050.071